Activation of the PI3K-AKT-mTOR signalling pathway is implicated in the progression of thyroid cancer [18–20], and the PI3K-AKT signalling pathway is involved in the regulation of the sialyltransferase family [11]. The gene discussed is MTOR; the disease is thyroid gland carcinoma.